Medicine
Bicillin C-R 900/300 900000 IU/300000 IU per 2 mL injectable suspension
Bicillin C-R 900/300 900000 IU/300000 IU per 2 mL injectable suspension is a prescription medicine containing Penicillin g benzathine and Penicillin g procaine for intramuscular use, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in a refrigerator, 2° to 8°C (36° to 46°F). Keep from freezing.
Key facts
- Active ingredient (INN)
- Penicillin g benzathine and Penicillin g procaine
- Brand
- Bicillin C-R 900/300
- Strength
- 900000 IU/300000 IU per 2 mL
- Dosage form
- Injectable suspension
- Route
- Intramuscular
- Packs
- 10 syringes
- Marketing authorisation holder
- Pfizer Laboratories
- Manufacturer
- Pfizer Laboratories
- Origin register
- US FDA, United States
- Storage
- Store in a refrigerator, 2° to 8°C (36° to 46°F). Keep from freezing.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 May 1953
- Identifiers
- RxCUI 836306, 836307DailyMed set ID ba7b9199-4710-4189-a85d-77ed75befe4dNDC 60793-602Application NDA050138
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 syringe in 1 package / 2 mL in 1 syringe | 60793-602-10 | Pfizer Laboratories | 18 May 1953 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 May 1953 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Penicillin g benzathine and Penicillin g procaine
Clinical summary
Penicillin g benzathine and Penicillin g procaine is a fixed-dose combination medicine. It is available as injectable suspension for intramuscular use. MedsAcross supplies Penicillin g benzathine and Penicillin g procaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Penicillin g benzathine and Penicillin g procaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BICILLIN CR prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
Need Bicillin C-R 900/300 900000 IU/300000 IU per 2 mL injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.